Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.
|
This activity is supported by independent educational grants from Celgene Corporation, Lilly USA, Inc. and Novartis Pharmaceuticals.
|
Monday, April 29, 2019
Registration: 11:00 AM - 11:30 AM
Program: 11:30 AM - 1:00 PM
Wynn Hotel
Room: Margaux 2
Las Vegas, NV
Please note: No additional fee is required to attend this CPE activity; however, registration to the Specialty Pharmacy Summit 2019 is required.
|
|
Click here to download the slides from this symposium.
To complete the evaluation go to www.ImpactEdu.net/PS19 and use code 0419.
|
|
Top Reasons to Attend
|
- Learn how to align specialty drug treatment algorithms with evidence-based recommendations
- Discover specialty pharmacy management opportunities to better manage clinical and economic results
- Hear recommendations from psoriatic disease clinical experts on how specialty pharmacists can deliver value-added services
|
Expert Faculty Presenters
|
|
|
|
|
Michael Zeglinski, RPh
Senior Vice President, Specialty Pharmacy
OptumRx®/BriovaRx®
|
|
Robin Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
|
|
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
|
|
|
|
Who Should Attend?
|
The target audience for this activity consists of specialty pharmacy professionals and other managed care pharmacy professionals attending the Specialty Pharmacy Summit 2019.
|
|
Statement of Need/Program Overview
|
Psoriasis and psoriatic arthritis presents a significant clinical and humanistic burden to patients and payers. Fortunately, there has been a marked increase in the number of safe and effective therapies to the disease. As a result, payers, specialty pharmacists, and affiliated providers are challenged to match patients with the most appropriate therapeutic option. This program will focus on the therapeutic options available to manage the spectrum of pathologic challenges confronted by patients with psoriatic disease which can help enable specialty pharmacy professionals to improve patient quality of life and clinical outcomes.
|
|
Educational Objectives
|
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Explain the pathophysiology and immunologic pathways of psoriatic disease
- Align psoriatic disease specialty drug treatment algorithms with evidence-based treatment recommendations
- Utilize care pathways as cost management and appropriate use tools in psoriatic disease
- Employ specialty pharmacy and disease management services for psoriatic disease patients
|
|
Agenda
|
Date and Time
Monday, April 29, 2019
Registration: 11:00 AM - 11:30 AM
Program: 11:30 AM - 1:00 PM
Wynn Hotel
Room: Margaux 2
Las Vegas, NV
|
|
11:30 AM
|
Pre-Activity Learning Assessment and Opening Comments/Overview
Michael Zeglinski, RPh
|
|
11:35 AM
|
Current Evidence-Based Recommendations for the Treatment of Psoriasis
Alan Menter, MD
|
|
11:55 AM
|
Current Evidence-Based Recommendations for the Treatment of Psoriatic Arthritis
Robin Dore, MD
|
|
12:15 AM
|
Specialty Pharmacy Management Opportunities for Psoriatic Disease
Michael Zeglinski, RPh
|
|
12:45 PM
|
Audience Q&A Session
Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
|
|
1:00 PM
|
Adjournment
|
|
Pharmacy Credit
 |
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0816-9999-19-130-L01-P
This activity is certified as Knowledge-based CPE.
|
Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.
Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE activity.
Please note: No additional fee is required to attend this CPE activity; however, registration to the Specialty Pharmacy Summit 2019 is required.
Pre-registration will close at 12:00 pm on April 28, 2019.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.
|
|
